Login

Tal Yalon, M.D., Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Thyroid & Parathyroid Surgery: Ask Mayo Clinic Health System

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Interview with Michael Riley, CEO of Group Ten Metals: Exploring Opportunities in the Stillwater Complex
00:10:00
Bridgewater Associates’ Greg Jensen Discusses Market Opportunities, Trump Policies, Political Risks, and AI-Driven Fund Launch on Bloomberg Open Interest
00:10:00
Strategic Vision for a Leading Uranium Company: Merging Strengths and Expanding Pipeline
00:10:00
Fastly CEO Todd Nightingale delivers closing remarks at Altitude 2022, sharing comments on the company's performance and future outlook.
00:10:00
Telkom CEO Sipho Maseko discusses his open letter to the government in an interview with Vuyo Mvoko on As It Happens.
00:10:00
Insights into the Copper Supply Chain and Market Dynamics
00:10:00
Air New Zealand CEO Greg Foran on Rising Airfare Prices and Inflation | Greg Foran, CEO, Air New Zealand Ltd .
00:10:00
Invests in the people products and processes that power commerce|Aubrie Pagano,General Partner,Alpaca VC
00:10:00
Arcosa Advocating for Real Change | Antonio Carrillo, CEO, Arcosa IncACA:NYQ
00:10:00
Executive Chairman Justyn Peters Discusses Project Progress and Market Challenges | Daniel Justyn Douglas Peters, Chairman, Neurizer Ltd.
00:10:00
A leading provider of critical decision support tools|Henry A. Fernandez,Chairman,Real Capital Analytics
00:10:00
Planet Labs' satellites monitor activities from potential deforestation to preventing tree branches from damaging power lines.|Will Marshall, co-founder & CEO of Planet Labs,

© 2017 - Neuhu+